We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best ...

AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Levi & Korsinsky, LLP notifies investors in Cerevel Therapeutics Holdings, Inc. ("Cerevel Therapeutics Holdings, Inc." or the "Company") of a class action securities ...

Zacks Research just trimmed its FY2025 earnings forecast for AbbVie, shaving it from $12.14 to $12.02 per share. This modest ...

This collaboration aims to leverage the ISPOR UAE Chapter’s extensive network and knowledge in HEOR and AbbVie’s scientific expertise ...